CG:600080 Ginwa Enterprise (Group) Inc

GINWA ENTERPRISE (GROUP) INC. is principally engaged in the manufacture and sale of pharmaceuticals. The Company's main product is jintiange capsules, used for treatment of osteoporosis. The Company provides products in various forms, including tablets, oral solutions, capsules and others. In addition, the Company involves in the provision of hotel services and operation of rental business. Through its subsidiaries, the Company is involved in hotel operation business, wholesale and retail of pharmaceuticals and medical devices, as well as television drama production businesses and others.

8.15 CNY
As of 01/19/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Unknown
Industry:  Drug Manufacturers-Specialty &
Index country:  China
Country of incorporation:  China
IPO date:  02/22/2018
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   3,191,458,816 CNY
Current dividend yield:   1.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy